D-017-2014 Class II Terminated

Recalled by Apotex Inc. — Toronto, N/A

FDA drug recall D-017-2014 was initiated by Apotex Inc. on Jul 17, 2013 and is designated Class II. Reason for recall: Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets. The recall status is terminated (terminated Aug 4, 2014). Affected quantity: 4,844 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 4, 2013
Initiation Date
Jul 17, 2013
Termination Date
Aug 4, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,844 bottles

Product description

Acyclovir Tablets USP 800 mg ,(NDC 60505-5307-1), Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for Apotex Corp.,Weston, Florida 33326.

Reason for recall

Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot # KF2199 Exp 07/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-017-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-017-2014. Report a data issue: hello@regdatalab.com.